ERBB2 and breast cancer: Single-cell analysis localized BTK transcripts primarily to myeloid and B cells.<h4>Conclusion</h4>BTK expression in BC reflects a proliferative and immune-active TME, particularly in TNBC and HER2-positive subtypes, but lacks prognostic or predictive value for NAC or PD-L1-based immunotherapy response.